Business Context and Reporting Period
Chemung Financial Corp (CHMG) is a financial holding company operating primarily through its subsidiary, Chemung Canal Trust Company. The company provides banking, financing, fiduciary, and wealth management services in New York State. This summary covers the unaudited quarterly report (Form 10-Q) for the period ended June 30, 2025.
Key Financial Metrics
| Metric | Q2 2025 (Three Months) | YTD 2025 (Six Months) | Q2 2024 (Three Months) | YTD 2024 (Six Months) |
|---|---|---|---|---|
| Net Interest Income | $20.8 million | $40.6 million | $17.8 million | $35.9 million |
| Non-Interest Income | ($10.7 million) | ($4.8 million) | $5.6 million | $11.3 million |
| Net Income (Loss) | ($6.5 million) | ($0.4 million) | $5.0 million | $12.0 million |
| Diluted EPS | ($1.35) | ($0.09) | $1.05 | $2.53 |
| Total Assets | $2.85 billion | $2.85 billion | $2.76 billion (Dec 31, 2024) | $2.76 billion (Dec 31, 2024) |
| Total Deposits | $2.47 billion | $2.47 billion | $2.40 billion (Dec 31, 2024) | $2.40 billion (Dec 31, 2024) |
| Allowance for Credit Losses | $22.7 million | $22.7 million | $21.4 million (Dec 31, 2024) | $21.4 million (Dec 31, 2024) |
| Net Interest Margin (FTE) | 3.05% | 3.00% | 2.66% | 2.69% |
Material Changes vs. Prior Period
- Net Loss Driven by Securities Sale: The company reported a net loss of $6.5 million for Q2 2025, a significant decline from the $5.0 million net income in Q2 2024. This was primarily due to a $17.5 million pre-tax loss recognized on the sale of available-for-sale securities.
- Balance Sheet Repositioning: Management sold approximately 40% of its available-for-sale securities portfolio (book value of $244.8 million) to reposition the balance sheet. Proceeds were used to pay down $155 million in wholesale funding (brokered deposits and FHLB advances) in July 2025.
- Capital Raise: On June 10, 2025, the company issued $45.0 million of 7.75% fixed-to-floating rate subordinated notes due 2035 to support regulatory capital ratios.
- Net Interest Income Growth: Despite the loss on securities, Net Interest Income increased 17.2% year-over-year to $20.8 million, driven by higher loan yields and lower deposit costs.
- Loan Portfolio Growth: Total loans increased 2.9% to $2.13 billion, with growth concentrated in commercial real estate (up $80.5 million) and home equity lines (up $8.3 million), offset by a decline in indirect consumer loans.
Guidance, Outlook, and Risks
- Strategic Outlook: Management intends to use remaining proceeds from the securities sale and subordinated debt issuance to fund organic loan growth in key expansion markets (Capital Region and Western New York).
- Non-GAAP Adjustments: Excluding the $17.5 million securities loss and a $0.6 million gain on the sale of a branch property, adjusted net income for Q2 2025 was $6.3 million ($1.31 per share), and adjusted net income for the six months ended June 30, 2025, was $12.3 million ($2.57 per share).
- Asset Quality: Non-performing loans decreased to $8.2 million (0.39% of total loans). The allowance for credit losses to non-performing loans ratio improved to 275.16%.
- Interest Rate Risk: Management estimates that an immediate 100 basis point increase in interest rates would positively impact net interest income by 4.51% over the next 12 months.
- Legal Proceedings: The company is pursuing a lawsuit against Pioneer Bank regarding a defaulted commercial credit facility, seeking recovery of approximately $3.7 million plus expenses.
Investor Verification Checklist
- Securities Portfolio Composition: Verify the remaining composition of the available-for-sale portfolio post-sale and the impact on future yield and liquidity.
- Wholesale Funding Maturity: Confirm the repayment of the $100 million in brokered deposits and $55 million in FHLB advances in July 2025 and assess the reliance on core deposits going forward.
- Subordinated Debt Terms: Review the specific terms of the new $45 million subordinated notes, including the floating rate mechanism post-2030 and redemption restrictions.
- Commercial Real Estate Concentration: Monitor the CRE concentration ratio (359.09% at the holding company level) and the impact of the new capital on regulatory compliance.
- Deferred Tax Asset Realization: Assess the company's strategy to utilize the $2.7 million deferred tax asset arising from the capital loss on securities sold by the REIT entity.